Clinical Trials Browser

Interventional × Venous Thromboembolism × Clear all

NCT07469488 2026-03-13

AmiCARE

Phase 4 Not yet recruiting

Classical hematologyThoracic

Carcinoma, Non-Small-Cell Lung, Venous Thromboembolism

NCT05171049 2026-02-23

ASTER

Phase 3 Terminated

Classical hematology

Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

NCT07399977 2026-02-12

Using a Blood Test and Software Tool to Guide Treatment for Venous Thromboembolism

Phase NA Recruiting

Classical hematology

Venous Thrombosis, Venous Thromboembolism

NCT07005024 2026-02-05

DOAC

Phase 3 Recruiting

Classical hematology

Neoplasms, Venous Thromboembolism

NCT07303816 2025-12-26

STAT-CAT

Phase 4 Not yet recruiting

Classical hematology

Neoplasms, Pulmonary Embolism, Venous Thromboembolism

NCT05171075 2025-12-19

MAGNOLIA

Phase 3 Active not recruiting

Classical hematologyGastrointestinal

Gastrointestinal Neoplasms, Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

NCT07292376 2025-12-18

Implementing VTE Prevention in Ambulatory Cancer Care

Phase NA Enrolling by invitation

Classical hematology

Neoplasms, Venous Thromboembolism

NCT03244020 2025-10-03

LMWH vs Aspirin for VTE Prophylaxis in Orthopaedic Oncology

Phase 4 Enrolling by invitation

Classical hematologySarcoma

Bone Neoplasms, Hematoma, Sarcoma, Venous Thromboembolism

NCT02066454 2025-08-13

MYELAXAT

Phase 3 Completed

Classical hematologyPlasma cell

Neoplasms, Plasma Cell, Venous Thromboembolism

NCT06451003 2025-07-31

Intervention to Improve Utilization of Extended Venous Thromboembolism Prophylaxis After Cancer Surgery

Phase NA Recruiting

Classical hematology

Neoplasms, Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

NCT06580223 2025-07-18

Aspirin or Rivaroxaban Thromboprophylaxis for Patients With Multiple Myeloma

Phase 3 Not yet recruiting

Classical hematologyPlasma cell

Multiple Myeloma, Venous Thromboembolism

NCT05920343 2025-07-10

PREVENT-GU

Phase 2/3 Recruiting

Classical hematologyGenitourinary

Urogenital Neoplasms, Urologic Neoplasms, Venous Thromboembolism

NCT05029063 2025-07-09

TRIM-Line

Phase 3 Recruiting

Classical hematology

Neoplasms, Venous Thromboembolism

NCT06129760 2025-07-09

Glioblastoma Remote Monitoring and Care - Research Protocol

Phase NA Recruiting

CNSClassical hematology

Glioblastoma, Seizures, Venous Thromboembolism

NCT03045406 2025-06-24

CARAVAGGIO

Phase 3 Completed

1,170 enrolled 11 charts

Classical hematology

Venous Thromboembolism

NCT06603870 2025-05-30

STREAM-Line

Phase 4 Recruiting

Classical hematology

Neoplasms, Venous Thromboembolism, Catheter-Related Infections, Upper Extremity Deep Vein Thrombosis

NCT06886516 2025-03-20

Apixaban in Thrombocytopenia

Phase EARLY_PHASE1 Recruiting

Classical hematology

Pulmonary Embolism, Thrombocytopenia, Thromboembolism, Thrombosis, Venous Thrombosis, Venous Thromboembolism

NCT01130025 2025-02-24

Long-Term Innohep® Treatment Versus a Vitamin K Antagonist (Warfarin) for the Treatment of Venous Thromboembolism (VTE) in Cancer

Phase 3 Completed

Classical hematology

Venous Thromboembolism

NCT04243122 2024-05-29

AIRPORT-MPN

Phase 2 Completed

Classical hematologyMyeloid

Myeloproliferative Disorders, Polycythemia Vera, Thrombocythemia, Essential, Venous Thromboembolism, Primary Myelofibrosis

NCT06314763 2024-04-30

ROSIE

Phase 4 Completed

Classical hematologyThoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Venous Thromboembolism

NCT03297359 2024-01-23

WAVe

Phase 2 Terminated

Classical hematologyOther

Neoplasms, Obesity, Venous Thromboembolism

NCT06196918 2024-01-09

Efficacy and Safety of Rivaroxaban in the Prevention of Venous Thromboembolism in Glioma Patients

Phase NA Unknown

CNSClassical hematology

Glioma, Dyskinesias, Venous Thromboembolism

NCT02744092 2023-10-03

CANVAS

Phase NA Completed

811 enrolled 19 charts

Classical hematology

Neoplasms, Pulmonary Embolism, Thrombosis, Venous Thrombosis, Venous Thromboembolism

NCT01583218 2023-08-07

APEX

Phase 3 Completed

7,513 enrolled 18 charts 1 FDA

Classical hematology

Venous Thromboembolism

NCT03090880 2022-11-17

PROVE

Phase 3 Terminated

Classical hematologyThoracic

Lung Neoplasms, Venous Thromboembolism

NCT04479579 2022-04-22

Improved Adherence With Extended Venous Thromboembolism Prophylaxis After Major Cancer Surgery

Phase 4 Completed

Classical hematology

Neoplasms, Venous Thromboembolism, Medication Adherence

NCT03988231 2021-10-08

Enoxaparin Versus Placebo for Venous Thromboembolism Prevention in Low Risk Cancer Patients After Surgical Procedures: a Randomized, Double Blind, Placebo Controlled Clinical Trial Pilot Study

Phase 4 Withdrawn

Classical hematology

Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

NCT02583191 2021-05-03

Rivaroxaban in the Treatment of Venous Thromboembolism (VTE) in Cancer Patients

Phase 3 Terminated

Classical hematology

Neoplasms, Venous Thromboembolism

NCT04106700 2021-02-15

Prophylaxis With Apixaban in Transplant Eligible Patients With Multiple Myeloma Receiving Induction Therapy With IMiDs

Phase 2 Terminated

Classical hematologyPlasma cell

Multiple Myeloma, Venous Thromboembolism

NCT02785757 2021-01-06

PROSPECT

Phase NA Unknown

Classical hematology

Adenocarcinoma, Venous Thromboembolism

NCT03006562 2020-08-05

PREVENTER

Phase 4 Terminated

501 enrolled 13 charts

Classical hematologyGenitourinary

Prostatic Neoplasms, Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

NCT02585713 2020-08-04

Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism

Phase 3 Completed

300 enrolled 11 charts

Classical hematology

Neoplasm Metastasis, Neoplasms, Pulmonary Embolism, Venous Thrombosis, Intracranial Thrombosis, Venous Thromboembolism, Mesenteric Ischemia

NCT02366871 2020-03-31

Oral Apixaban (Eliquis) Versus Enoxaparin (Lovenox) for Thromboprophylaxis in Women With Suspected Pelvic Malignancy

Phase 2 Completed

400 enrolled 16 charts

Classical hematology

Venous Thromboembolism

NCT03471468 2020-02-17

DOMICA

Phase NA Terminated

Classical hematologyGastrointestinal

Pancreatic Neoplasms, Stomach Neoplasms, Venous Thromboembolism

NCT02958969 2019-12-17

Apixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple Myeloma

Phase 4 Completed

50 enrolled 5 charts

Classical hematologyPlasma cell

Multiple Myeloma, Venous Thromboembolism

NCT03195010 2019-10-21

Management of Platelet Transfusion Therapy in Patients With Blood Cancer or Treatment-Induced Thrombocytopenia

Phase 2 Terminated

4 enrolled 13 charts

Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Hematologic Diseases, Myelodysplastic Syndromes, Thrombocytopenia, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Biphenotypic, Acute, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Lymphoma, B-Cell, Lymphoma, T-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Venous Thromboembolism, Primary Myelofibrosis

NCT02555878 2019-09-12

A Study to Evaluate the Efficacy and Safety of Rivaroxaban Venous Thromboembolism (VTE) Prophylaxis in Ambulatory Cancer Participants

Phase 3 Completed

841 enrolled 24 charts

Classical hematology

Neoplasms, Venous Thromboembolism

NCT02935530 2019-05-14

Thromboprophylaxis After Surgery for Gynecologic Malignancy in China

Phase 3 Completed

Classical hematology

Genital Neoplasms, Female, Venous Thromboembolism

NCT02285738 2019-05-08

Anti-Platelet and Statin Therapy to Prevent Cancer-Associated Thrombosis

Phase EARLY_PHASE1 Completed

Classical hematology

Neoplasms, Thrombosis, Venous Thromboembolism

NCT03240120 2019-04-17

A Study of Dabigatran Etexilate as Primary Treatment of Malignancy Associated Venous Thromboembolism

Phase 3 Unknown

Classical hematology

Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

NCT00952380 2019-04-16

Fragmin for the Treatment of Acute VTE in Pediatric Cancer Patients

Phase 2 Completed

38 enrolled 30 charts

Classical hematology

Venous Thromboembolism

NCT02073682 2019-03-06

Cancer Venous Thromboembolism (VTE)

Phase 3 Completed

1,046 enrolled 24 charts

Classical hematology

Neoplasms, Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

NCT02048865 2018-11-20

AVERT

Phase 2 Completed

Classical hematology

Neoplasms, Venous Thromboembolism

NCT01817257 2018-10-29

ALICAT

Phase 2 Terminated

Classical hematology

Neoplasms, Pulmonary Embolism, Thrombosis, Venous Thrombosis, Venous Thromboembolism

NCT02746185 2018-08-13

CASTA-DIVA

Phase 3 Completed

Classical hematology

Neoplasms, Venous Thromboembolism

NCT01524653 2018-07-10

DISOLVE

Phase 2 Completed

Classical hematology

Neoplasm Metastasis, Neoplasms, Venous Thrombosis, Venous Thromboembolism

NCT03083782 2017-10-11

ACT

Phase 1 Completed

Classical hematology

Venous Thromboembolism

NCT00981903 2017-07-06

Tinzaparin for Primary Treatment and Extended Secondary Prophylaxis of Venous Thromboembolism in Patients With Cancer

Phase 2 Terminated

Classical hematology

Neoplasms, Venous Thromboembolism

NCT01448746 2017-02-07

Optimal Prophylactic Method of Venous Thromboembolism (VTE)

Phase 3 Unknown

Classical hematologyGastrointestinal

Stomach Neoplasms, Venous Thromboembolism

NCT00966277 2016-12-12

Dalteparin for Primary Venous Thromboembolism (VTE) Prophylaxis in Pancreatic Cancer Patients

Phase 4 Completed

87 enrolled 9 charts

Classical hematologyGastrointestinal

Pancreatic Neoplasms, Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism